
Indraprastha Medical Corporation Ltd
NSE:INDRAMEDCO

Wall Street
Price Targets
INDRAMEDCO Price Targets Summary
Indraprastha Medical Corporation Ltd
According to Wall Street analysts, the average 1-year price target for
INDRAMEDCO
is 601.8 INR
with a low forecast of 595.9 INR and a high forecast of 619.5 INR.
Operating Income
Forecast
Operating Income Estimate
Indraprastha Medical Corporation Ltd
For the last 8 years the
compound annual growth rate for
Indraprastha Medical Corporation Ltd's operating income is
17%.
The projected
CAGR
for the next 4 years is
-11%.
Net Income
Forecast
Net Income Estimate
Indraprastha Medical Corporation Ltd
For the last 8 years the
compound annual growth rate for
Indraprastha Medical Corporation Ltd's net income is
23%.
The projected
CAGR
for the next 3 years is
19%.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is INDRAMEDCO's stock price target?
Price Target
601.8
INR
According to Wall Street analysts, the average 1-year price target for
INDRAMEDCO
is 601.8 INR
with a low forecast of 595.9 INR and a high forecast of 619.5 INR.
What is Indraprastha Medical Corporation Ltd's Revenue forecast?
Projected CAGR
9%
For the last 8 years the
compound annual growth rate for
Indraprastha Medical Corporation Ltd's revenue is
6%.
The projected
CAGR
for the next 3 years is
9%.
What is Indraprastha Medical Corporation Ltd's Operating Income forecast?
Projected CAGR
-11%
For the last 8 years the
compound annual growth rate for
Indraprastha Medical Corporation Ltd's operating income is
17%.
The projected
CAGR
for the next 4 years is
-11%.
What is Indraprastha Medical Corporation Ltd's Net Income forecast?
Projected CAGR
19%
For the last 8 years the
compound annual growth rate for
Indraprastha Medical Corporation Ltd's net income is
23%.
The projected
CAGR
for the next 3 years is
19%.